Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients.
Kupin
W
W
Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan 48202, USA.
Venkat
K K
KK
Goggins
M
M
Abouljoud
M
M
Escobar
F
F
Mozes
M
M
D000804:Angiotensin II; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D004656:Enalapril / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D016030:Kidney Transplantation; D017706:Lisinopril / Q000627:therapeutic use; D019808:Losartan; D008297:Male; D011086:Polycythemia / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications; D013777:Tetrazoles / Q000627:therapeutic use*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001713:Biphenyl Compounds; D007093:Imidazoles; D013777:Tetrazoles; D000804:Angiotensin II; D004656:Enalapril; D003404:Creatinine; D017706:Lisinopril; D019808:Losartan